WASHINGTON — The U.S. Bureau of Prisons has begun implementing restrictions on certain forms of gender-affirming care for transgender inmates following policy changes introduced by the Trump administration, prompting legal challenges and criticism from advocacy groups while federal officials defend the measures as consistent with administration priorities.
The policy changes stem from executive actions issued earlier this year directing federal agencies to recognize sex based on biological characteristics and review programs related to gender identity. The Bureau of Prisons subsequently revised guidance affecting medical treatment, housing assignments and other accommodations for transgender inmates, according to court filings and agency statements.
Justice Department officials said the Bureau of Prisons would continue providing constitutionally required medical care to inmates while reevaluating certain treatments and procedures. Federal officials have argued that prison policies must align with the administration’s interpretation of federal law and executive directives.
“The Bureau of Prisons remains committed to providing appropriate medical care to all individuals in its custody,” the agency said in statements filed in ongoing litigation.
Civil rights organizations and attorneys representing transgender inmates have challenged the restrictions in federal court. Several lawsuits contend that limits on hormone therapy, gender-related medical treatments and housing placements could expose inmates to health risks and violate constitutional protections. In some cases, federal judges have issued temporary orders requiring the continuation of previously approved treatments while litigation proceeds.
According to court records, the policy changes have affected transgender inmates housed in federal correctional facilities across multiple states. The exact number of inmates impacted remains unclear.
Medical organizations, including groups representing physicians and mental health professionals, have long maintained that gender-affirming care can be medically necessary for some patients diagnosed with gender dysphoria. Advocacy groups cited those positions in challenging the federal policy revisions.
Administration officials, however, have argued that the federal government has authority to determine which medical treatments are funded and provided within correctional institutions. Supporters of the changes have said prison systems should reevaluate policies adopted under previous administrations.
The issue has emerged amid broader national debates over transgender healthcare, education policies and participation in public programs. Several states have enacted or proposed measures affecting access to gender-related medical treatment, while courts continue to weigh legal challenges involving constitutional and statutory protections.
Federal judges reviewing the prison policies have not issued final rulings on the underlying legal questions. Court proceedings remain active in several jurisdictions, and appeals are expected regardless of the outcomes in lower courts.
As of Thursday, the Bureau of Prisons said it was continuing to implement revised policies while complying with applicable court orders. Details regarding any additional changes to inmate healthcare procedures remain under review, and ongoing litigation is expected to determine how the policies are applied in the future.
